Department of Respiratory, Critical Care, and Sleep Medicine, Erlanger Baroness Hospital, University of Tennessee Health Science Center, Chattanooga, Tennessee, USA.
Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, USA.
Am J Hypertens. 2022 Oct 3;35(10):875-883. doi: 10.1093/ajh/hpac091.
African Americans have a higher prevalence of resistant hypertension compared with Caucasians. Racial differences in obstructive sleep apnea (OSA) and increased aldosterone level may explain the racial disparity in resistant hypertension prevalence. Therefore, the purpose of this study is to investigate if aldosterone level and hypertension status differ by risks for OSA (e.g., obesity, loud snoring, and daytime sleepiness) and how aldosterone level varies with hypertension severity and control among African Americans.
A cross-sectional analysis was performed using baseline data on 5,052 African American adults in the Jackson Heart Study to investigate the relationships of interest using multivariable linear and multinomial logistic regression models adjusted for potential confounders. Risks for OSA were defined by a "risk score" consisting of the number of risks for OSA.
Of the 5,052 participants, 623 had no risks for OSA. Body mass index was the highest among those with a risk score of 6. About 39% of the sample had no hypertension, 29% had controlled hypertension, 26% had uncontrolled hypertension, and 6% had resistant hypertension. Higher odds of having uncontrolled hypertension or resistant hypertension were present in those with a higher risk score compared with those without risks for OSA. Log-aldosterone level increased with each additional risk for OSA (P-trend <0.05). Similarly, log-aldosterone also increased with more severe hypertension (P-trend <0.001). The highest aldosterone level was found in those with resistant hypertension that was inadequately controlled with medications.
Risks for OSA were positively associated with resistant hypertension and higher aldosterone level in African American adults.
与白种人相比,非裔美国人的耐药性高血压更为普遍。阻塞性睡眠呼吸暂停(OSA)和醛固酮水平升高的种族差异可能解释了耐药性高血压流行率的种族差异。因此,本研究旨在探讨醛固酮水平和高血压状况是否因 OSA 的风险因素(如肥胖、打鼾和白天嗜睡)而有所不同,以及醛固酮水平如何随非裔美国人的高血压严重程度和控制程度而变化。
使用 Jackson 心脏研究中 5052 名非裔美国成年人的基线数据进行横断面分析,使用多变量线性和多项逻辑回归模型来研究相关关系,并调整了潜在的混杂因素。OSA 的风险因素通过由 OSA 风险因素数量组成的“风险评分”来定义。
在 5052 名参与者中,有 623 人没有 OSA 的风险因素。在风险评分 6 分的参与者中,体重指数最高。大约 39%的样本没有高血压,29%的高血压得到了控制,26%的高血压没有得到控制,6%的高血压是耐药性的。与没有 OSA 风险因素的参与者相比,风险评分较高的参与者更有可能患有不受控制的高血压或耐药性高血压。每增加一个 OSA 风险因素,log-醛固酮水平都会升高(P 趋势 <0.05)。同样,log-醛固酮水平也随着高血压的严重程度增加而升高(P 趋势 <0.001)。在药物治疗未充分控制的耐药性高血压患者中,醛固酮水平最高。
在非裔美国成年人中,OSA 的风险因素与耐药性高血压和更高的醛固酮水平呈正相关。